| Acronym |
Full Name |
Score |
Rating |
Judge me |
Search |
| PI |
phosphatidylinositol |
289 |
10 |
good
bad
|
 |
| PI |
pulsatility index |
255 |
8 |
good
bad
|
|
| PI |
phosphate |
232 |
10 |
good
bad
|
|
| PI |
Propidium iodide |
224 |
8 |
good
bad
|
|
| PI |
protease inhibitor |
121 |
3 |
good
bad
|
|
| PI |
point |
120 |
5 |
good
bad
|
|
| PI |
phosphoinositide |
86 |
9 |
good
bad
|
|
| PI |
postinoculation |
67 |
3 |
good
bad
|
|
| PI |
points |
50 |
5 |
good
bad
|
|
| PI |
postinfection |
50 |
5 |
good
bad
|
|
| PI |
plaque index |
48 |
9 |
good
bad
|
|
| PI |
proliferation index |
46 |
2 |
good
bad
|
|
| PI |
proliferative index |
39 |
4 |
good
bad
|
|
| PI |
protease inhibitors |
38 |
8 |
good
bad
|
|
| PI |
persistently infected |
26 |
5 |
good
bad
|
|
| PI |
post infection |
25 |
11 |
good
bad
|
|
| PI |
post inoculation |
24 |
2 |
good
bad
|
|
| PI |
post-infection |
23 |
12 |
good
bad
|
|
| PI |
phosphatidyl inositol |
23 |
4 |
good
bad
|
|
| PI |
post-inoculation |
19 |
5 |
good
bad
|
|
| PI |
phosphorus |
18 |
8 |
good
bad
|
|
| PI |
pressure |
15 |
0 |
good
bad
|
|
| PI |
pancreatic insufficiency |
14 |
8 |
good
bad
|
|
| PI |
pulse interval |
14 |
5 |
good
bad
|
|
| PI |
proactive interference |
13 |
0 |
good
bad
|
|
| PI |
pars intermedia |
12 |
11 |
good
bad
|
|
| PI |
pulsatility indices |
11 |
8 |
good
bad
|
|
| PI |
ponderal index |
10 |
3 |
good
bad
|
|
| PI |
phagocytic index |
9 |
2 |
good
bad
|
|
| PI |
proinsulin |
8 |
2 |
good
bad
|
|
| PI |
permeability index |
7 |
11 |
good
bad
|
|
| PI |
pain intensity |
7 |
11 |
good
bad
|
|
| PI |
proliferating index |
7 |
7 |
good
bad
|
|
| PI |
prognostic index |
7 |
4 |
good
bad
|
|
| PI |
pulsatility |
6 |
9 |
good
bad
|
|
| PI |
perfusion imaging |
6 |
2 |
good
bad
|
|
| PI |
Periodontal Index |
5 |
12 |
good
bad
|
|
| PI |
PISTILLATA |
5 |
11 |
good
bad
|
|
| PI |
performance index |
5 |
11 |
good
bad
|
|
| PI |
phosphotyrosine interaction |
5 |
9 |
good
bad
|
|
| PI |
perfusion index |
5 |
9 |
good
bad
|
|
| PI |
phosphoinositides |
5 |
9 |
good
bad
|
|
| PI |
Pneumatosis intestinalis |
5 |
9 |
good
bad
|
|
| PI |
penetration index |
5 |
8 |
good
bad
|
|
| PI |
povidone iodine |
5 |
8 |
good
bad
|
|
| PI |
phosphocreatine (PCr) to inorganic phosphate |
5 |
8 |
good
bad
|
|
| PI |
phosphatidyl-inositol |
5 |
6 |
good
bad
|
|
| PI |
plaque |
5 |
5 |
good
bad
|
|
| PI |
proteinase inhibitor |
4 |
11 |
good
bad
|
|
| PI |
Persistent infection |
4 |
10 |
good
bad
|
|
| PI |
polyphosphoinositide |
4 |
9 |
good
bad
|
|
| PI |
pulvinar |
4 |
9 |
good
bad
|
|
| PI |
Protein I |
4 |
8 |
good
bad
|
|
| PI |
plasma insulin |
4 |
7 |
good
bad
|
|
| PI |
1-protease inhibitor |
4 |
5 |
good
bad
|
|
| PI |
Proliferation indices |
4 |
4 |
good
bad
|
|
| PI |
postinjection |
4 |
4 |
good
bad
|
|
| PI |
Principal Investigator |
4 |
3 |
good
bad
|
|
| PI |
pork insulin |
4 |
2 |
good
bad
|
|
| PI |
phosphatidylinositide |
3 |
12 |
good
bad
|
|
| PI |
pentamidine isethionate |
3 |
10 |
good
bad
|
|
| PI |
preparatory interval |
3 |
9 |
good
bad
|
|
| PI |
paternity index |
3 |
8 |
good
bad
|
|
| PI |
performance improvement |
3 |
8 |
good
bad
|
|
| PI |
putatively immune |
3 |
8 |
good
bad
|
|
| PI |
phosphates |
3 |
7 |
good
bad
|
|
| PI |
pulsatility indexes |
3 |
7 |
good
bad
|
|
| PI |
percutaneous intervention |
3 |
7 |
good
bad
|
|
| PI |
proportional-integral |
3 |
6 |
good
bad
|
|
| PI |
Prevotella intermedia |
3 |
5 |
good
bad
|
|
| PI |
peripheral iridectomy |
3 |
5 |
good
bad
|
|
| PI |
promoter I |
3 |
5 |
good
bad
|
|
| PI |
pars intercerebralis |
3 |
5 |
good
bad
|
|
| PI |
primary isolates |
3 |
5 |
good
bad
|
|
| PI |
presence of inorganic phosphate |
3 |
5 |
good
bad
|
|
| PI |
post injection |
3 |
4 |
good
bad
|
|
| PI |
proteinase inhibitors |
3 |
3 |
good
bad
|
|
| PI |
pulse index |
3 |
3 |
good
bad
|
|
| PI |
pressure intercept |
3 |
2 |
good
bad
|
|
| PI |
Phosphocreatine (PCr) and inorganic phosphate |
3 |
2 |
good
bad
|
|
| PI |
protein intake |
3 |
2 |
good
bad
|
|
| PI |
povidone-iodine |
3 |
-2 |
good
bad
|
|
| PI |
peptide that stimulates phosphoinositide |
2 |
18 |
good
bad
|
|
| PI |
1-proteinase inhibitor |
2 |
14 |
good
bad
|
|
| PI |
Pharmacoeconomic Initiative |
2 |
13 |
good
bad
|
|
| PI |
phosphorous |
2 |
11 |
good
bad
|
|
| PI |
phosphatidylinositides |
2 |
11 |
good
bad
|
|
| PI |
positive index |
2 |
10 |
good
bad
|
|
| PI |
alpha |
2 |
10 |
good
bad
|
|
| PI |
orthophosphate |
2 |
10 |
good
bad
|
|
| PI |
phosphatidylinositols |
2 |
10 |
good
bad
|
|
| PI |
pristinamycin I |
2 |
10 |
good
bad
|
|
| PI |
proliferation |
2 |
10 |
good
bad
|
|
| PI |
perceptual identification |
2 |
10 |
good
bad
|
|
| PI |
prolonged infusion |
2 |
10 |
good
bad
|
|
| PI |
proactive inhibition |
2 |
9 |
good
bad
|
|
| PI |
plant introduction |
2 |
9 |
good
bad
|
|
| PI |
Phosphatidylglycerol (PG) and phosphatidylinositol |
2 |
9 |
good
bad
|
|
| PI |
Pacific Islanders |
2 |
9 |
good
bad
|
|
| PI |
glycosyl-phosphatidylinositol |
2 |
9 |
good
bad
|
|
| PI |
plasma infusion |
2 |
8 |
good
bad
|
|
| PI |
post instillation |
2 |
8 |
good
bad
|
|
| PI |
personality inventory |
2 |
8 |
good
bad
|
|
| PI |
proportional integral |
2 |
8 |
good
bad
|
|
| PI |
p85 regulatory subunit of phosphatidylinositol |
2 |
8 |
good
bad
|
|
| PI |
post insemination |
2 |
7 |
good
bad
|
|
| PI |
Protection Index |
2 |
7 |
good
bad
|
|
| PI |
pathogenicity island |
2 |
7 |
good
bad
|
|
| PI |
primary infection |
2 |
7 |
good
bad
|
|
| PI |
peroxidizability index |
2 |
7 |
good
bad
|
|
| PI |
propidium iodine |
2 |
7 |
good
bad
|
|
| PI |
proteins with isoelectric points |
2 |
6 |
good
bad
|
|
| PI |
phosphate ions |
2 |
6 |
good
bad
|
|
| PI |
pulsitility index |
2 |
6 |
good
bad
|
|
| PI |
preservation injury |
2 |
5 |
good
bad
|
|
| PI |
pulsatile index |
2 |
5 |
good
bad
|
|
| PI |
pulmonary insufficiency |
2 |
5 |
good
bad
|
|
| PI |
pulse intervals |
2 |
5 |
good
bad
|
|
| PI |
position of inorganic orthophosphate |
2 |
4 |
good
bad
|
|
| PI |
pancreatic islets |
2 |
4 |
good
bad
|
|
| PI |
protracted infusion |
2 |
4 |
good
bad
|
|
| PI |
phosphatidic acid (PA) and phosphatidylinositol |
2 |
3 |
good
bad
|
|
| PI |
preparatory intervals |
2 |
3 |
good
bad
|
|
| PI |
psychodynamic-interpersonal |
2 |
3 |
good
bad
|
|
| PI |
pulsation index |
2 |
3 |
good
bad
|
|
| PI |
plasmin inhibitor |
2 |
3 |
good
bad
|
|
| PI |
postinspiratory |
2 |
2 |
good
bad
|
|
| PI |
postimplantation |
2 |
2 |
good
bad
|
|
| PI |
proliferation indexes |
2 |
1 |
good
bad
|
|
| PI |
alpha-1-proteinase inhibitor |
2 |
1 |
good
bad
|
|
| PI |
progression index |
2 |
0 |
good
bad
|
|
| PI |
primary |
1 |
15 |
good
bad
|
|
| PI |
pepsin |
1 |
15 |
good
bad
|
|
| PI |
pentamidine-isethionate |
1 |
14 |
good
bad
|
|
| PI |
protein isoelectric point |
1 |
14 |
good
bad
|
|
| PI |
phosphatidyl [3H] inositol |
1 |
14 |
good
bad
|
|
| PI |
PAI-1 is due to phosphatidylinositol |
1 |
14 |
good
bad
|
|
| PI |
PCr/inorganic phosphate |
1 |
14 |
good
bad
|
|
| PI |
persists 6 weeks postinfection |
1 |
14 |
good
bad
|
|
| PI |
physical intimidation |
1 |
13 |
good
bad
|
|
| PI |
proliferating indexes |
1 |
13 |
good
bad
|
|
| PI |
pH at isoelectric point |
1 |
13 |
good
bad
|
|
| PI |
phospholipid |
1 |
13 |
good
bad
|
|
| PI |
parameters investigated were plaque index |
1 |
13 |
good
bad
|
|
| PI |
phosphoinositidic |
1 |
13 |
good
bad
|
|
| PI |
alpha1-proteinase inhibitor |
1 |
13 |
good
bad
|
|
| PI |
prognostic |
1 |
13 |
good
bad
|
|
| PI |
phosphorylation of phosphatidylinositol |
1 |
12 |
good
bad
|
|
| PI |
parthenogenesis induction in haplodiploid species |
1 |
12 |
good
bad
|
|
| PI |
Na-phosphate |
1 |
12 |
good
bad
|
|
| PI |
peak incremental indices |
1 |
12 |
good
bad
|
|
| PI |
Parsonnet index |
1 |
11 |
good
bad
|
|
| PI |
phosphatidylinositol 4-phosphate [PI(4)P] from phosphatidylinositol |
1 |
11 |
good
bad
|
|
| PI |
phosphate concentrations |
1 |
11 |
good
bad
|
|
| PI |
paradigms of transient |
1 |
11 |
good
bad
|
|
| PI |
perfusion-weighted |
1 |
11 |
good
bad
|
|
| PI |
Phox (PX) domains are phosphoinositide |
1 |
11 |
good
bad
|
|
| PI |
P induced phosphatidylinositol |
1 |
11 |
good
bad
|
|
| PI |
p85alpha regulatory subunit of phosphatidylinositol |
1 |
11 |
good
bad
|
|
| PI |
PME isoforms exhibiting a wide isoelectric-point |
1 |
11 |
good
bad
|
|
| PI |
pearling index |
1 |
11 |
good
bad
|
|
| PI |
Padua Inventory |
1 |
11 |
good
bad
|
|
| PI |
panniculus index |
1 |
11 |
good
bad
|
|
| PI |
peak interval |
1 |
11 |
good
bad
|
|
| PI |
percentage index |
1 |
11 |
good
bad
|
|
| PI |
parasite index |
1 |
11 |
good
bad
|
|
| PI |
phosphorylation and phosphatidylinositol |
1 |
11 |
good
bad
|
|
| PI |
phagocytosis inhibitor |
1 |
11 |
good
bad
|
|
| PI |
probability of ascertainment |
1 |
11 |
good
bad
|
|
| PI |
phosphorylating phosphatidylinositol |
1 |
11 |
good
bad
|
|
| PI |
phospholipids |
1 |
11 |
good
bad
|
|
| PI |
PI 3-kinase C2beta utilizes phosphatidylinositol |
1 |
11 |
good
bad
|
|
| PI |
prepared a phosphatidylinositol |
1 |
11 |
good
bad
|
|
| PI |
PI-TPalphaI containing a phosphatidylinositol |
1 |
11 |
good
bad
|
|
| PI |
perceptually impaired |
1 |
11 |
good
bad
|
|
| PI |
p110 subunit of phosphatidylinositol |
1 |
10 |
good
bad
|
|
| PI |
prepubertal children |
1 |
10 |
good
bad
|
|
| PI |
p85 subunit of phosphatidylinositol |
1 |
10 |
good
bad
|
|
| PI |
Performance-by-intensity |
1 |
10 |
good
bad
|
|
| PI |
P-arginine)/ |
1 |
10 |
good
bad
|
|
| PI |
N(alpha)-tert-butyloxycarbonyl-N |
1 |
10 |
good
bad
|
|
| PI |
Pulsatility-Index |
1 |
10 |
good
bad
|
|
| PI |
pulsing interval |
1 |
10 |
good
bad
|
|
| PI |
pressure reading |
1 |
10 |
good
bad
|
|
| PI |
phosphoinositide hydrolysis |
1 |
10 |
good
bad
|
|
| PI |
phosphodiesters and inorganic phosphate |
1 |
10 |
good
bad
|
|
| PI |
lipophilicity |
1 |
10 |
good
bad
|
|
| PI |
phenylephrine-induced contractions and phosphatidylinositol |
1 |
10 |
good
bad
|
|
| PI |
parasternal intercostal |
1 |
10 |
good
bad
|
|
| PI |
post implant |
1 |
10 |
good
bad
|
|
| PI |
proportionality index |
1 |
10 |
good
bad
|
|
| PI |
partition coefficient |
1 |
10 |
good
bad
|
|
| PI |
primary specificity site |
1 |
10 |
good
bad
|
|
| PI |
phorbol 12-myristate 13-acetate and ionomycin |
1 |
10 |
good
bad
|
|
| PI |
polyimide |
1 |
10 |
good
bad
|
|
| PI |
proteins with iso-electric points |
1 |
10 |
good
bad
|
|
| PI |
product of the reaction |
1 |
10 |
good
bad
|
|
| PI |
protein synthesis and phosphoinositide |
1 |
10 |
good
bad
|
|
| PI |
patients detected by newborn screening |
1 |
10 |
good
bad
|
|
| PI |
progressive incremental |
1 |
10 |
good
bad
|
|
| PI |
puncture (PP) or injection |
1 |
9 |
good
bad
|
|
| PI |
pristinamycin factor I |
1 |
9 |
good
bad
|
|
| PI |
V-propidium iodide |
1 |
9 |
good
bad
|
|
| PI |
poly-phosphoinositides |
1 |
9 |
good
bad
|
|
| PI |
post-initial infection |
1 |
9 |
good
bad
|
|
| PI |
Rhodamine-propidium iodide |
1 |
9 |
good
bad
|
|
| PI |
pump infusion |
1 |
9 |
good
bad
|
|
| PI |
Puffin Island |
1 |
9 |
good
bad
|
|
| PI |
pseudointima |
1 |
9 |
good
bad
|
|
| PI |
primary insomnia |
1 |
9 |
good
bad
|
|
| PI |
1-4GlcN-phosphatidylinositol |
1 |
9 |
good
bad
|
|
| PI |
potential regulator of all phosphatidylinositol |
1 |
9 |
good
bad
|
|
| PI |
primary isolate |
1 |
9 |
good
bad
|
|
| PI |
Polyinosinic acid |
1 |
9 |
good
bad
|
|
| PI |
polypeptide with isoelectric point |
1 |
9 |
good
bad
|
|
| PI |
prostaglandin (PGI2) receptors on phosphoinositide |
1 |
9 |
good
bad
|
|
| PI |
pixel index |
1 |
9 |
good
bad
|
|
| PI |
pressure at the airway opening |
1 |
9 |
good
bad
|
|
| PI |
porcine insulin |
1 |
9 |
good
bad
|
|
| PI |
Phytophthora infestans |
1 |
9 |
good
bad
|
|
| PI |
patients had higher inorganic phosphate |
1 |
9 |
good
bad
|
|
| PI |
perimeter |
1 |
9 |
good
bad
|
|
| PI |
package insert |
1 |
9 |
good
bad
|
|
| PI |
pancreatic insufficient |
1 |
9 |
good
bad
|
|
| PI |
pharmacologic immunosuppressive therapy |
1 |
9 |
good
bad
|
|
| PI |
GlcN-phosphatidylinositol |
1 |
9 |
good
bad
|
|
| PI |
2-a]indole |
1 |
9 |
good
bad
|
|
| PI |
pacing-induced ischemia |
1 |
9 |
good
bad
|
|
| PI |
phosphocreatine (PCr)/inorganic orthophosphate |
1 |
9 |
good
bad
|
|
| PI |
penicillin-intermediate |
1 |
9 |
good
bad
|
|
| PI |
partially immune |
1 |
9 |
good
bad
|
|
| PI |
performance/intensity |
1 |
9 |
good
bad
|
|
| PI |
patients were scored for plaque |
1 |
9 |
good
bad
|
|
| PI |
pancreatic exocrine insufficiency |
1 |
9 |
good
bad
|
|
| PI |
phenotypic distribution of alpha-1-antitrypsin variants |
1 |
9 |
good
bad
|
|
| PI |
permeability-increasing activity |
1 |
9 |
good
bad
|
|
| PI |
partially filled porphyrin 3e |
1 |
9 |
good
bad
|
|
| PI |
phosphatidylserine (PS) and phosphatidylositol |
1 |
9 |
good
bad
|
|
| PI |
pathway regulated by phosphatidylinositol |
1 |
9 |
good
bad
|
|
| PI |
affinity-purified fraction |
1 |
9 |
good
bad
|
|
| PI |
peptides to stimulate phosphoinositide |
1 |
9 |
good
bad
|
|
| PI |
[32P]orthophosphate |
1 |
8 |
good
bad
|
|
| PI |
perfusion indices |
1 |
8 |
good
bad
|
|
| PI |
Cd13 |
1 |
8 |
good
bad
|
|
| PI |
paramagnetic reagents |
1 |
8 |
good
bad
|
|
| PI |
protease inibithors |
1 |
8 |
good
bad
|
|
| PI |
plus ifosfamide |
1 |
8 |
good
bad
|
|
| PI |
plus insulin |
1 |
8 |
good
bad
|
|
| PI |
presence of (32P) inorganic phosphate |
1 |
8 |
good
bad
|
|
| PI |
phosphates ([3H]IPs) from [3H]phosphoinositide |
1 |
8 |
good
bad
|
|
| PI |
period of 12 weeks post-infection |
1 |
8 |
good
bad
|
|
| PI |
persistent increase in phosphoinositide |
1 |
8 |
good
bad
|
|
| PI |
post-injury |
1 |
8 |
good
bad
|
|
| PI |
Proteins within an isoelectric point |
1 |
8 |
good
bad
|
|
| PI |
phonemically implausible |
1 |
8 |
good
bad
|
|
| PI |
poly[-6-beta-D-glucopyranosyl-(1-->2)-glycerol phosphate] |
1 |
8 |
good
bad
|
|
| PI |
pancreatic injury |
1 |
8 |
good
bad
|
|
| PI |
permanently implantable |
1 |
8 |
good
bad
|
|
| PI |
protein's isoelectric point |
1 |
8 |
good
bad
|
|
| PI |
polyphosphoinositides (PPI) but not phosphatidylinositol |
1 |
8 |
good
bad
|
|
| PI |
potency being phosphatidylinositol |
1 |
8 |
good
bad
|
|
| PI |
phenyl isocyanate |
1 |
8 |
good
bad
|
|
| PI |
polymer of hundreds of phosphate |
1 |
8 |
good
bad
|
|
| PI |
pacing interval |
1 |
8 |
good
bad
|
|
| PI |
pacemaker-independent |
1 |
8 |
good
bad
|
|
| PI |
perturbations in phosphoinositide |
1 |
8 |
good
bad
|
|
| PI |
prevention indicators |
1 |
8 |
good
bad
|
|
| PI |
phospholipids phosphatidylethanolamine (PE) and phosphatidylinositol |
1 |
8 |
good
bad
|
|
| PI |
PDGF addition and one |
1 |
8 |
good
bad
|
|
| PI |
PI 157440 |
1 |
8 |
good
bad
|
|
| PI |
propidium diiodide |
1 |
8 |
good
bad
|
|
| PI |
PCNA index |
1 |
8 |
good
bad
|
|
| PI |
passive incontinence |
1 |
8 |
good
bad
|
|
| PI |
reliability |
1 |
8 |
good
bad
|
|
| PI |
patients treated with HIV-protease inhibitors |
1 |
8 |
good
bad
|
|
| PI |
signs--partial imitation |
1 |
8 |
good
bad
|
|
| PI |
patients with alpha 1-proteinase inhibitor |
1 |
8 |
good
bad
|
|
| PI |
peak increase |
1 |
8 |
good
bad
|
|
| PI |
pathogenic integral |
1 |
8 |
good
bad
|
|
| PI |
prostaglandin inhibition |
1 |
8 |
good
bad
|
|
| PI |
peak intensity |
1 |
8 |
good
bad
|
|
| PI |
pressure swing developed during inspiration |
1 |
8 |
good
bad
|
|
| PI |
putative immune individuals |
1 |
8 |
good
bad
|
|
| PI |
pressure of the pleural liquid |
1 |
8 |
good
bad
|
|
| PI |
path integration |
1 |
8 |
good
bad
|
|
| PI |
post-injection |
1 |
7 |
good
bad
|
|
| PI |
procedure generates unconventional surface pressure |
1 |
7 |
good
bad
|
|
| PI |
Prolongation Index |
1 |
7 |
good
bad
|
|
| PI |
postimmunization |
1 |
7 |
good
bad
|
|
| PI |
proinsulin intermediates |
1 |
7 |
good
bad
|
|
| PI |
Patient Identified |
1 |
7 |
good
bad
|
|
| PI |
proliferative index of the epithelium |
1 |
7 |
good
bad
|
|
| PI |
patency on day 8 postinfection |
1 |
7 |
good
bad
|
|
| PI |
permeability indices |
1 |
7 |
good
bad
|
|
| PI |
proliferative |
1 |
7 |
good
bad
|
|
| PI |
peroxidases with isoelectric point |
1 |
7 |
good
bad
|
|
| PI |
patients with Parkinson's disease |
1 |
7 |
good
bad
|
|
| PI |
postinfliction interval |
1 |
7 |
good
bad
|
|
| PI |
protein-I |
1 |
7 |
good
bad
|
|
| PI |
pressures |
1 |
7 |
good
bad
|
|
| PI |
perception index |
1 |
7 |
good
bad
|
|
| PI |
peaks at isoelectric points |
1 |
7 |
good
bad
|
|
| PI |
prematurity index |
1 |
7 |
good
bad
|
|
| PI |
Predictive indicators |
1 |
7 |
good
bad
|
|
| PI |
protein indices |
1 |
7 |
good
bad
|
|
| PI |
probabilities of Markov process |
1 |
7 |
good
bad
|
|
| PI |
produce beta-lactamases with isoelectric points |
1 |
7 |
good
bad
|
|
| PI |
povidone iodine solution |
1 |
7 |
good
bad
|
|
| PI |
periodontal conditions |
1 |
7 |
good
bad
|
|
| PI |
products of the phosphatidylinositol |
1 |
7 |
good
bad
|
|
| PI |
potassium iodide |
1 |
7 |
good
bad
|
|
| PI |
periodic injection |
1 |
7 |
good
bad
|
|
| PI |
Postischemia |
1 |
7 |
good
bad
|
|
| PI |
periodontal disease |
1 |
7 |
good
bad
|
|
| PI |
prolonged ischemia |
1 |
7 |
good
bad
|
|
| PI |
per capita income |
1 |
7 |
good
bad
|
|
| PI |
Like |
1 |
7 |
good
bad
|
|
| PI |
pyritinol on phosphatidylinositol |
1 |
7 |
good
bad
|
|
| PI |
phosphatase hydrolyzing phosphatidylinositol |
1 |
7 |
good
bad
|
|
| PI |
32P-phosphatidylinositol |
1 |
7 |
good
bad
|
|
| PI |
porcine influenza virus |
1 |
7 |
good
bad
|
|
| PI |
porcelain inlays |
1 |
7 |
good
bad
|
|
| PI |
phosphoenzyme formation from either inorganic orthophosphate |
1 |
7 |
good
bad
|
|
| PI |
proximal tubular phosphate |
1 |
7 |
good
bad
|
|
| PI |
phosphocreatine and inorganic phosphate |
1 |
7 |
good
bad
|
|
| PI |
Phosphocreatine (PCr)/inorganic phosphate |
1 |
7 |
good
bad
|
|
| PI |
polypeptide |
1 |
7 |
good
bad
|
|
| PI |
polymorphism |
1 |
7 |
good
bad
|
|
| PI |
plasma inorganic P |
1 |
7 |
good
bad
|
|
| PI |
polyhydroxy lipid |
1 |
7 |
good
bad
|
|
| PI |
phosphatidylinositol hydrolysis |
1 |
7 |
good
bad
|
|
| PI |
PLC-mediated phosphoinositide |
1 |
7 |
good
bad
|
|
| PI |
porcine influenza |
1 |
7 |
good
bad
|
|
| PI |
Physical Impairment |
1 |
7 |
good
bad
|
|
| PI |
phosphotidylinositol |
1 |
7 |
good
bad
|
|
| PI |
physical identity |
1 |
7 |
good
bad
|
|
| PI |
positive indices |
1 |
7 |
good
bad
|
|
| PI |
proteins and phosphatidylinositol |
1 |
7 |
good
bad
|
|
| PI |
positive affect |
1 |
7 |
good
bad
|
|
| PI |
pig insulin |
1 |
7 |
good
bad
|
|
| PI |
protein and its locus |
1 |
7 |
good
bad
|
|
| PI |
phosphate of muscle tissue |
1 |
7 |
good
bad
|
|
| PI |
pyrophosphate (PPi) versus phosphate |
1 |
7 |
good
bad
|
|
| PI |
presence of Ca2+ and phosphate |
1 |
6 |
good
bad
|
|
| PI |
pressure-impedance |
1 |
6 |
good
bad
|
|
| PI |
mGSTP1 |
1 |
6 |
good
bad
|
|
| PI |
psychiatrically-ill |
1 |
6 |
good
bad
|
|
| PI |
performance indices |
1 |
6 |
good
bad
|
|
| PI |
pressure irrigation |
1 |
6 |
good
bad
|
|
| PI |
parameter |
1 |
6 |
good
bad
|
|
| PI |
base-pairs upstream |
1 |
6 |
good
bad
|
|
| PI |
platelet increment |
1 |
6 |
good
bad
|
|
| PI |
hydrostatic |
1 |
6 |
good
bad
|
|
| PI |
portal images |
1 |
6 |
good
bad
|
|
| PI |
plasma inorganic phosphorus |
1 |
6 |
good
bad
|
|
| PI |
pronounced increase in inorganic phosphate |
1 |
6 |
good
bad
|
|
| PI |
phosphoglycerides phosphatidylinositol |
1 |
6 |
good
bad
|
|
| PI |
serum-protease-inhibitor |
1 |
6 |
good
bad
|
|
| PI |
pindolol |
1 |
6 |
good
bad
|
|
| PI |
Pilocarpine increased in vivo phosphoinositide |
1 |
6 |
good
bad
|
|
| PI |
phospholipase C-gamma2 (PLC-gamma2) and phosphatidylinositol |
1 |
6 |
good
bad
|
|
| PI |
Pearl Index |
1 |
6 |
good
bad
|
|
| PI |
primary inhibition |
1 |
6 |
good
bad
|
|
| PI |
pars interpolaris |
1 |
6 |
good
bad
|
|
| PI |
plasma colloid osmotic pressure |
1 |
6 |
good
bad
|
|
| PI |
Prevention indexes |
1 |
6 |
good
bad
|
|
| PI |
phospholipid standards phosphatidylinositol |
1 |
6 |
good
bad
|
|
| PI |
purulent intoxication |
1 |
6 |
good
bad
|
|
| PI |
phosphadityl inositol |
1 |
6 |
good
bad
|
|
| PI |
post-irradiation |
1 |
6 |
good
bad
|
|
| PI |
protein 2 (CBP2) and alpha-1 antitrypsin |
1 |
6 |
good
bad
|
|
| PI |
pseudo-intima |
1 |
6 |
good
bad
|
|
| PI |
permanent illumination |
1 |
6 |
good
bad
|
|
| PI |
panicle initiation |
1 |
6 |
good
bad
|
|
| PI |
postinduction |
1 |
6 |
good
bad
|
|
| PI |
porphyria (VP) and the alpha-1-antitrypsin |
1 |
6 |
good
bad
|
|
| PI |
povidone-iodine solution |
1 |
6 |
good
bad
|
|
| PI |
peritoneal irritation |
1 |
6 |
good
bad
|
|
| PI |
protective index |
1 |
6 |
good
bad
|
|
| PI |
protein kinase and phosphatidylinositol |
1 |
6 |
good
bad
|
|
| PI |
postinoculation of sporozoites |
1 |
6 |
good
bad
|
|
| PI |
proteins differing in isoelectric point |
1 |
6 |
good
bad
|
|
| PI |
predominant phosphoinositide |
1 |
6 |
good
bad
|
|
| PI |
porcine |
1 |
6 |
good
bad
|
|
| PI |
p85 alpha subunit of phosphoinositide |
1 |
6 |
good
bad
|
|
| PI |
personal interviews |
1 |
6 |
good
bad
|
|
| PI |
protein-interaction |
1 |
5 |
good
bad
|
|
| PI |
PDGF-treated cells contained a phosphatidylinositol |
1 |
5 |
good
bad
|
|
| PI |
produced an increase in Na+/phosphate |
1 |
5 |
good
bad
|
|
| PI |
pyrophosphate (PPi) and inorganic orthophosphate |
1 |
5 |
good
bad
|
|
| PI |
pyromellitimide |
1 |
5 |
good
bad
|
|
| PI |
photoreactive derivative of inorganic phosphate |
1 |
5 |
good
bad
|
|
| PI |
product that accumulated was Glc-PO4-Man-Man-GlcN-lyso-1-O-alkylphosphatidylinositol |
1 |
5 |
good
bad
|
|
| PI |
proliferative (proliferating cell nuclear antigen-labeling) index |
1 |
5 |
good
bad
|
|
| PI |
possessed one isoelectric point of |
1 |
5 |
good
bad
|
|
| PI |
pi-back-bonding from the Fe d |
1 |
5 |
good
bad
|
|
| PI |
post-inspiratory |
1 |
5 |
good
bad
|
|
| PI |
pinhole imaging |
1 |
5 |
good
bad
|
|
| PI |
PDGF-stimulated binding of phosphatidylinositol |
1 |
5 |
good
bad
|
|
| PI |
palmar interosseous |
1 |
5 |
good
bad
|
|
| PI |
pirouette |
1 |
5 |
good
bad
|
|
| PI |
progesterone-independent |
1 |
5 |
good
bad
|
|
| PI |
porphyrins because of a specific metal(d)-porphyrin |
1 |
5 |
good
bad
|
|
| PI |
propidium iodine (BrdU) |
1 |
5 |
good
bad
|
|
| PI |
pulmonary infiltration |
1 |
5 |
good
bad
|
|
| PI |
pressurized hand-held inhaler |
1 |
5 |
good
bad
|
|
| PI |
protein identity |
1 |
5 |
good
bad
|
|
| PI |
postexcitatory inhibition |
1 |
5 |
good
bad
|
|
| PI |
acidic |
1 |
5 |
good
bad
|
|
| PI |
presence of excess inorganic phosphate |
1 |
5 |
good
bad
|
|
| PI |
pressure in capillaries (Pc) and interstitium |
1 |
5 |
good
bad
|
|
| PI |
pressure caused by colloid osmotic forces |
1 |
5 |
good
bad
|
|
| PI |
pressure (Pv) on interstitial fluid hydrostatic |
1 |
5 |
good
bad
|
|
| PI |
polymorphic immunocytoma |
1 |
5 |
good
bad
|
|
| PI |
parainfluenza |
1 |
5 |
good
bad
|
|
| PI |
plasma concentration of inorganic phosphate |
1 |
5 |
good
bad
|
|
| PI |
precursor (big ET-1) on phosphoinositide |
1 |
5 |
good
bad
|
|
| PI |
postoperative ileus |
1 |
5 |
good
bad
|
|
| PI |
pregnane indices |
1 |
5 |
good
bad
|
|
| PI |
precursors had isoelectric points |
1 |
5 |
good
bad
|
|
| PI |
peaking at day 3 postinoculation |
1 |
5 |
good
bad
|
|
| PI |
plaque/calculus index |
1 |
5 |
good
bad
|
|
| PI |
potease inhibitor |
1 |
5 |
good
bad
|
|
| PI |
post infectionem |
1 |
5 |
good
bad
|
|
| PI |
prescription isodose volume |
1 |
5 |
good
bad
|
|
| PI |
protease inhibitor 1 |
1 |
4 |
good
bad
|
|
| PI |
promoted amylase secretion and phosphatidylinositol |
1 |
4 |
good
bad
|
|
| PI |
Proteins having an isoelectric point |
1 |
4 |
good
bad
|
|
| PI |
prostaglandin (PG) F2 alpha-stimulated phosphoinositide |
1 |
4 |
good
bad
|
|
| PI |
protocols incorporated SYBR-14 and propidium iodide |
1 |
4 |
good
bad
|
|
| PI |
1-[4'-(3H)-phenyl]imidazole |
1 |
4 |
good
bad
|
|
| PI |
alpha1-proteinase inhibitor (alpha1 |
1 |
4 |
good
bad
|
|
| PI |
P is phosphate |
1 |
4 |
good
bad
|
|
| PI |
plasma iron |
1 |
4 |
good
bad
|
|
| PI |
parameters and isoelectric points |
1 |
4 |
good
bad
|
|
| PI |
proportional and integral |
1 |
4 |
good
bad
|
|
| PI |
proximal intestine |
1 |
4 |
good
bad
|
|
| PI |
trypsin-2-alpha1-proteinase inhibitor |
1 |
4 |
good
bad
|
|
| PI |
positively linked to phosphoinositide |
1 |
4 |
good
bad
|
|
| PI |
position of the inorganic phosphate |
1 |
4 |
good
bad
|
|
| PI |
positive for the anti-phosphatidylinositol |
1 |
4 |
good
bad
|
|
| PI |
precursor cell |
1 |
4 |
good
bad
|
|
| PI |
presynaptic inhibition |
1 |
4 |
good
bad
|
|
| PI |
postinsemination |
1 |
4 |
good
bad
|
|
| PI |
percent inhibition |
1 |
4 |
good
bad
|
|
| PI |
presence of intranucleaur pseudo-inclusion bodies |
1 |
4 |
good
bad
|
|
| PI |
performance |
1 |
4 |
good
bad
|
|
| PI |
phosphatidylcholine (PC) greater than phosphatidylinositol |
1 |
4 |
good
bad
|
|
| PI |
Periodontal indices utilized were Plaque Index |
1 |
4 |
good
bad
|
|
| PI |
portal infusion |
1 |
4 |
good
bad
|
|
| PI |
phosphate are known to inhibit Na(+)-phosphate |
1 |
4 |
good
bad
|
|
| PI |
pipobroman |
1 |
4 |
good
bad
|
|
| PI |
potency of phosphatidylinositol |
1 |
4 |
good
bad
|
|
| PI |
pirimicarb |
1 |
4 |
good
bad
|
|
| PI |
PCNA labelling indices |
1 |
4 |
good
bad
|
|
| PI |
phosphatidylserine (PS) and phosphatidylinositol |
1 |
4 |
good
bad
|
|
| PI |
phosphate ion |
1 |
4 |
good
bad
|
|
| PI |
private industry |
1 |
4 |
good
bad
|
|
| PI |
peak |
1 |
4 |
good
bad
|
|
| PI |
Placebo |
1 |
4 |
good
bad
|
|
| PI |
plethysmography index |
1 |
4 |
good
bad
|
|
| PI |
protein with isoelectric point |
1 |
3 |
good
bad
|
|
| PI |
postero-inferior |
1 |
3 |
good
bad
|
|
| PI |
positivity index |
1 |
3 |
good
bad
|
|
| PI |
polybutadiene (DPB)/polyisoprene |
1 |
3 |
good
bad
|
|
| PI |
polysomy index |
1 |
3 |
good
bad
|
|
| PI |
pulmonary irritation |
1 |
3 |
good
bad
|
|
| PI |
p85alpha and phosphatidylinositol |
1 |
3 |
good
bad
|
|
| PI |
arachidonyl-phosphatidylinositol |
1 |
3 |
good
bad
|
|
| PI |
power density |
1 |
3 |
good
bad
|
|
| PI |
pulse inversion (PPI) and pulse inversion |
1 |
3 |
good
bad
|
|
| PI |
planar imaging |
1 |
3 |
good
bad
|
|
| PI |
pathologically increased pulsatility indices |
1 |
3 |
good
bad
|
|
| PI |
pectin-insulin |
1 |
3 |
good
bad
|
|
| PI |
partial index |
1 |
3 |
good
bad
|
|
| PI |
placebo group |
1 |
3 |
good
bad
|
|
| PI |
proportional-plus-integral |
1 |
3 |
good
bad
|
|
| PI |
produced when inorganic phosphate |
1 |
3 |
good
bad
|
|
| PI |
sigma |
1 |
3 |
good
bad
|
|
| PI |
pattern I by Appleton |
1 |
3 |
good
bad
|
|
| PI |
Protease inhibitor phenotype |
1 |
3 |
good
bad
|
|
| PI |
phosphatidylserine and phosphatidylinositol |
1 |
3 |
good
bad
|
|
| PI |
phase |
1 |
3 |
good
bad
|
|
| PI |
Predominantly inhibitory cells |
1 |
3 |
good
bad
|
|
| PI |
prediction intervals |
1 |
3 |
good
bad
|
|
| PI |
plasma phosphate |
1 |
3 |
good
bad
|
|
| PI |
phosphatidylinositol pathway |
1 |
2 |
good
bad
|
|
| PI |
plasminogen inactivator |
1 |
2 |
good
bad
|
|
| PI |
alpha1-protease inhibitor |
1 |
2 |
good
bad
|
|
| PI |
pulsativity index |
1 |
2 |
good
bad
|
|
| PI |
phosphatidyl inositide |
1 |
2 |
good
bad
|
|
| PI |
plasmin inhibition |
1 |
2 |
good
bad
|
|
| PI |
phosphatidylinositol membrane anchor |
1 |
2 |
good
bad
|
|
| PI |
pituitary isografts |
1 |
2 |
good
bad
|
|
| PI |
5-bisphosphate |
1 |
2 |
good
bad
|
|
| PI |
pyrethrin I |
1 |
2 |
good
bad
|
|
| PI |
phosphate residues |
1 |
2 |
good
bad
|
|
| PI |
postischemic |
1 |
2 |
good
bad
|
|
| PI |
pre-inoculation |
1 |
2 |
good
bad
|
|
| PI |
protein of isoelectric point |
1 |
2 |
good
bad
|
|
| PI |
postintraocular injection |
1 |
2 |
good
bad
|
|
| PI |
protein in a phosphorylated form |
1 |
2 |
good
bad
|
|
| PI |
post-ischemia |
1 |
2 |
good
bad
|
|
| PI |
Padmakar-Ivan |
1 |
2 |
good
bad
|
|
| PI |
photoxic index |
1 |
2 |
good
bad
|
|
| PI |
parallel conductance (G |
1 |
2 |
good
bad
|
|
| PI |
prognostic indexes |
1 |
2 |
good
bad
|
|
| PI |
polymer of hundreds of orthophosphate |
1 |
2 |
good
bad
|
|
| PI |
proportion index |
1 |
1 |
good
bad
|
|
| PI |
pixel intensity |
1 |
1 |
good
bad
|
|
| PI |
phosphoinositol |
1 |
1 |
good
bad
|
|
| PI |
plasma Ca++ and inorganic P |
1 |
1 |
good
bad
|
|
| PI |
prophase I |
1 |
1 |
good
bad
|
|
| PI |
pied |
1 |
1 |
good
bad
|
|
| PI |
production of 3'-phosphorylated phosphoinositide |
1 |
1 |
good
bad
|
|
| PI |
Platelet inhibition |
1 |
1 |
good
bad
|
|
| PI |
plus inorganic phosphate |
1 |
1 |
good
bad
|
|
| PI |
Pool I |
1 |
1 |
good
bad
|
|
| PI |
pituitary |
1 |
0 |
good
bad
|
|
| PI |
processing-independent |
1 |
0 |
good
bad
|
|
| PI |
psychosocial intervention |
1 |
0 |
good
bad
|
|
| PI |
placental insufficiency |
1 |
0 |
good
bad
|
|
| PI |
panoramic index |
1 |
0 |
good
bad
|
|
| PI |
PPi and as inorganic orthophosphate |
1 |
0 |
good
bad
|
|
| PI |
precede the breakdown of phosphatidylinositol |
1 |
0 |
good
bad
|
|
| PI |
plasma membrane by phosphatidylinositol |
1 |
0 |
good
bad
|
|
| PI |
prescribing information |
1 |
-1 |
good
bad
|
|
| PI |
peaking 7 days postinfection |
1 |
-1 |
good
bad
|
|
| PI |
per nucleotide |
1 |
-1 |
good
bad
|
|
| PI |
delta |
1 |
-1 |
good
bad
|
|
| PI |
pineal antigonadotropin |
1 |
-1 |
good
bad
|
|
| PI |
polymorphism data indicated that nucleotide diversity |
1 |
-2 |
good
bad
|
|
| PI |
peptides induced phosphoinositide |
1 |
-2 |
good
bad
|
|